Literature DB >> 20500508

Validating bladder cancer xenograft bioluminescence with magnetic resonance imaging: the significance of hypoxia and necrosis.

Peter C Black1, Anil Shetty, Gordon A Brown, Emilio Esparza-Coss, Adam R Metwalli, Piyush K Agarwal, David J McConkey, John D Hazle, Colin P N Dinney.   

Abstract

OBJECTIVE: To assess the correlation in orthotopic bladder xenografts of bioluminescence imaging (BLI) with tumour volume as determined by magnetic resonance imaging (MRI), and to define the potential role of hypoxia and necrosis in the relationship between BLI and tumour volume at autopsy.
MATERIALS AND METHODS: Orthotopic bladder tumours were established in nude mice with KU7 and 253J B-V cells expressing luciferase. BLI and MRI were performed weekly. Tumour volume was calculated from MR images at each time point. Autopsy was performed 4 weeks after inoculation and 45 min after injection of piminidazole. haematoxylin and eosin staining and immunohistochemical analysis of piminidazole adduct formation were performed on 1-mm step-sections through frozen whole bladder specimens to assess necrosis and hypoxia, respectively. CD31 staining was used to evaluate vascularity. Relative volumes of each specimen containing total tumour, hypoxic tumour and necrotic tumour were quantified.
RESULTS: The correlation between MRI volume and BLI was weak in KU7 xenografts (R(2) < 0.1) but strong in 253J B-V (R(2) = 0.93 at 4 weeks). KU7 xenografts had vasculature only peripherally and showed extensive hypoxic and necrotic areas. After subtraction of necrotic areas, the correlation of BLI to viable tumour volume improved (R(2) = 0.42).
CONCLUSION: The correlation between tumour BLI and tumour size varies by cell line and is poor in xenografts that rapidly outgrow their vascular supply and develop broad areas of hypoxia and necrosis. However, in these cases BLI does yield information about the amount of viable tumour, and should therefore still be considered as a useful imaging method.
© 2010 THE AUTHORS. JOURNAL COMPILATION © 2010 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2010        PMID: 20500508     DOI: 10.1111/j.1464-410X.2010.09424.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  20 in total

Review 1.  Modeling human bladder cancer.

Authors:  Cassandra Ringuette-Goulet; Stéphane Bolduc; Frédéric Pouliot
Journal:  World J Urol       Date:  2018-06-14       Impact factor: 4.226

2.  Integrin α3β1 can function to promote spontaneous metastasis and lung colonization of invasive breast carcinoma.

Authors:  Katherine N Gibson-Corley; Mary E Herndon; Bo Zhou; Yihan Sun; Elisabeth Gustafson-Wagner; Melissa Teoh-Fitzgerald; Frederick E Domann; Michael D Henry; Christopher S Stipp
Journal:  Mol Cancer Res       Date:  2013-09-03       Impact factor: 5.852

3.  Development of a murine intravesical orthotopic human bladder cancer (mio-hBC) model.

Authors:  Peter A Raven; Ninadh M D'Costa; Igor Moskalev; Zheng Tan; Sebastian Frees; Claudia Chavez-Munoz; Alan I So
Journal:  Am J Clin Exp Urol       Date:  2018-12-20

4.  Construction and identification of the adenoviral vector with dual reporter gene for multimodality molecular imaging.

Authors:  Yi-Fan Wang; Ting Liu; Yu-Lin Guo; Fa-Bao Gao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-08-01

Review 5.  Modelling bladder cancer in mice: opportunities and challenges.

Authors:  Takashi Kobayashi; Tomasz B Owczarek; James M McKiernan; Cory Abate-Shen
Journal:  Nat Rev Cancer       Date:  2015-01       Impact factor: 60.716

6.  A continuum mechanical framework for modeling tumor growth and treatment in two- and three-phase systems.

Authors:  Cass T Miller; William G Gray; Bernhard A Schrefler
Journal:  Arch Appl Mech       Date:  2021-06-09       Impact factor: 2.467

7.  An orthotopic bladder cancer model for gene delivery studies.

Authors:  Laura Kasman; Christina Voelkel-Johnson
Journal:  J Vis Exp       Date:  2013-12-01       Impact factor: 1.355

8.  Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach.

Authors:  Wolfgang Jäger; Igor Moskalev; Claudia Janssen; Tetsutaro Hayashi; Shannon Awrey; Kilian M Gust; Alan I So; Kaixin Zhang; Ladan Fazli; Estelle Li; Joachim W Thüroff; Dirk Lange; Peter C Black
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

9.  Cucurbit [7] uril encapsulated cisplatin overcomes resistance to cisplatin induced by Rab25 overexpression in an intraperitoneal ovarian cancer model.

Authors:  Natividad Gomez-Roman; Fiona McGregor; Nial J Wheate; Jane A Plumb
Journal:  J Ovarian Res       Date:  2015-09-18       Impact factor: 4.234

10.  Longitudinal imaging of cancer cell metastases in two preclinical models: a correlation of noninvasive imaging to histopathology.

Authors:  Pavan P Adiseshaiah; Nimit L Patel; Lilia V Ileva; Joseph D Kalen; Diana C Haines; Scott E McNeil
Journal:  Int J Mol Imaging       Date:  2014-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.